Vaxcyte, Inc is hiring: Associate Director, SEC Reporting & Technical Accounting

Associate Director, SEC Reporting & Technical Accounting Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high‑fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well‑defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re‑innovate the way vaccines are delivered. AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness‑first, inclusive approach to collaboration and vigorous debate that advances our business objectives. MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary The Associate Director, SEC Reporting & Technical Accounting will serve as a key contributor to the company’s external reporting and technical accounting function. Reporting to the Senior Director, Technical Accounting & SEC Reporting, this role will be highly hands‑on, owning the preparation and execution of SEC filings and technical accounting analyses while also managing one direct report. This role is ideal for a technically strong accounting professional who enjoys operating in the details, partnering cross‑functionally, and helping build processes in a growing public biotechnology company. Essential Functions SEC Reporting (Hands‑On Execution) Own the preparation of quarterly and annual SEC filings, including Forms 10‑Q, 10‑K, and 8‑K Prepare and/or review primary financial statements, footnotes, and related disclosures in accordance with U.S. GAAP and SEC requirements Draft and support MD&A disclosures, with emphasis on R&D, G&A, stock‑based compensation, and other pre‑revenue biotech‑specific areas Coordinate the quarterly close‑to‑reporting process across Accounting, FP&A, Legal, and external auditors Support earnings release tie‑outs and disclosure controls Technical Accounting Support technical accounting assessments and documentation for complex transactions, including: Collaboration, licensing, and R&D‑related arrangements Equity and equity‑linked financing transactions Other complex and other non‑routine transactions Research new accounting standards and SEC guidance; assess applicability and implementation impact Draft clear, well‑supported technical accounting memos and communicate conclusions to stakeholders People Management Manage and mentor one direct report, providing coaching, review, and development support Review work products to ensure accuracy, quality, and adherence to timelines Foster strong execution discipline and continuous improvement within the reporting function Process Improvement & Scaling Help design and enhance scalable SEC reporting and technical accounting processes as the company grows Partner with cross‑functional teams to ensure accounting and reporting considerations are incorporated into business decisions Support SOX and internal control documentation related to SEC reporting and technical accounting as applicable Requirements Bachelor’s degree in Accounting or related field; CPA strongly preferred with a minimum 10 years of progressive accounting experience, including: Public accounting experience (Big 4 or national firm strongly preferred) and/or direct SEC reporting experience at a public company. Other combinations of education and/or experience may be considered. Strong technical knowledge of U.S. GAAP and SEC reporting requirements Excellent written and verbal communication skills Highly detail‑oriented with strong execution skills Comfortable operating in a fast‑paced, evolving environment Strong ownership mindset with the ability to balance deadlines and quality Collaborative, proactive, and solutions‑oriented Ability to work onsite 3 days per week required; and more often based on business needs. Compensation The compensation package will be competitive and includes comprehensive benefits and an equity component. Salary Range: $184,000 - $215,000 (SF Bay Area). Salary ranges for non‑California locations may vary. We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status. Voluntary Self‑Identification For government reporting purposes, we ask candidates to respond to the below self‑identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file. As set forth in Vaxcyte’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. We also ask for voluntary reporting of disability as part of federal contract compliance. You may choose to disclose any of the following conditions: Alcohol or other substance use disorder; Autoimmune disorder such as lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS; Blind or low vision; Cancer (past or present); Cardiovascular or heart disease; Celiac disease; Cerebral palsy; Deaf or serious difficulty hearing; Diabetes; Disfigurement; Epilepsy or other seizure disorder; Gastrointestinal disorders; Intellectual or developmental disability; Mental health conditions; Missing limbs or partially missing limbs; Mobility impairment; Nervous system condition; Neurodivergence; Partial or complete paralysis; Pulmonary or respiratory conditions; Short stature; Traumatic brain injury. PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete. #J-18808-Ljbffr